CCA
IMGN

Childress Capital Advisors’s Immunogen Inc IMGN Stock Holding History

Childress Capital Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-718
Closed -$5K – 1023
2020
Q4 		$5K Buy
+718
New +$4.19K ﹤0.01% 784

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Childress Capital Advisors's IMGN Position: Q1 2021 in Review

Childress Capital Advisors sold out of Immunogen Inc (IMGN) in Q1 2021, closing a stake of 718 shares — an estimated $5K sold.

Childress Capital Advisors first reported a position in IMGN in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2021.

  • Childress Capital Advisors reported no remaining Immunogen Inc position as of Q1 2021 after selling out during the quarter.
  • Childress Capital Advisors sold 718 Immunogen Inc shares in Q1 2021, an estimated $5K.
  • Childress Capital Advisors first reported a position in Immunogen Inc in Q4 2020 and held it in 1 quarter.
  • Childress Capital Advisors's Immunogen Inc position peaked at $5K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.